DSpace at RU >

Search Results

Results 1-50 of 99.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2012	Clinical challenges on how to optimise the use of drugs beyond the label	van Elk, B.; Kruger-Peters, S.; Torqui, A.; Leufkens, H.; Hekster, Y.A.
	2011	[Pitfalls in the treatment of neuropathic pain in patients with cancer]	Schalkwijk, A.; Verhagen, C.A.H.H.V.M.; Engels, Y.M.P.; Hekster, Y.A.; Vissers, K.C.P.
	2011	Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study	Bemt, B.J.F van den; Broeder, A. den; Wolbink, G.J.; Hekster, Y.A.; Riel, P.L. van; Benraad, B.; Hoogen, F.H. Van den
	2011	Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis	Bemt, B.J.F van den; Broeder, A. den; Hoogen, F.H. Van den; Benraad, B.; Hekster, Y.A.; van Riel, P.L.; Lankveld, W.G.J.M. van
	2010	Over regelen	Hekster, Y.A.
	2009	Hulpstoffen in geneesmiddelen voor kinderen: functies en toxiciteit. Farmacotherapie bij kinderen	Lagas-de Graaf, W.; Hekster, Y.A.
	2009	Requirements for generic anti-epileptic medicines: a regulatory perspective.	Maliepaard, M.; Hekster, Y.A.; Kappelle, A.C.; Puijenbroek, E.P. van; Elferink, A.J.; Welink, J.; Gispen-de Wied, C.C.; Lekkerkerker, F.J.
	2009	Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.	Bemt, B.J.F. van den; Hoogen, F.H.J. van den; Benraad, B.; Hekster, Y.A.; Riel, P.L.C.M. van; Lankveld, W.G.J.M. van
	2009	The impact of side effects on long-term retention in three new antiepileptic drugs.	Bootsma, H.P.; Ricker, L.; Hekster, Y.A.; Hulsman, J.; Lambrechts, D.; Majoie, M.; Schellekens, A.; Krom, M. de; Aldenkamp, A.P.
	2008	Drug treatment-related factors of inadequate seizure control.	Handoko, K.B.; Rijkom, JE Zwart-van; Visee, H.F.; Hermens, W.A.; Hekster, Y.A.; Egberts, T.C.G.
	2008	Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.	Verhagen, C.C.; Niezink, A.G.; Engels, Y.M.P.; Hekster, Y.A.; Doornebal, J.J.; Vissers, K.C.P.
	2008	Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.	Bemt, B.J. van den; Broeder, AA den; Snijders, G.F.; Hekster, Y.A.; Riel, P.L.C.M. van; Benraad, B.; Wolbink, G.J.; Hoogen, F.H.J. van den
	2008	Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring.	Handoko, K.B.; Puijenbroek, E.P. van; Bijl, A.H.; Hermens, W.A.; Rijkom, JE Zwart-van; Hekster, Y.A.; Egberts, T.C.G.
	2007	Afbakening aanbevolen: Geneesmiddelenonderzoek is in de WMO geen eenduidig begrip.	Agt, F.M. van; Hekster, Y.A.; Damen, L.M.; Verlaan, M.; Prick, M.J.J.; Huysmans, F.T.M.
	2007	Levetiracetam intraveneus, ook bij de behandeling van status epilepticus? : Onderzoek dringend gewenst	Meer, L.T. van der; Kanter, C.T.M.M. de; Hekster, Y.A.; Kappelle, A.C.
	2007	A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.	Knoester, P.D.; Deckers, C.L.P.; Termeer, E.H.; Boendermaker, A.J.; Kotsopoulos, I.A.; Krom, M.C.T.F.M. de; Keyser, T.; Renier, W.O.; Hekster, Y.A.; Severens, H.L.
	2006	The complexities of ethical evaluation of genomics research.	Hoedemaekers, R.H.M.V.; Gordijn, B.; Hekster, Y.A.; Agt, F.M. van
	2006	Gestructureerd patientendossier Proces tot implementatie als kwaliteitsinstrument en eerste resultaten in de patientenzorg.	Vink-van Kimmenade, N.; Keyser, A.J.M.; Groenewoud, J.; Moret-Hartman, M.; Hekster, Y.A.
	2006	Transmissie van infecties: Literatuuronderzoek en enquete over risico bij gebruik van parenteralia voor meerdere patiernten.	Lee, M.J. van der; Niessen, M.; Loeffen, F.L.A.; Voss, A.; Hekster, Y.A.
	2006	Movement disorders induced by gastrointestinal drugs: two paediatric cases.	Elzinga-Huttenga, J.; Hekster, Y.A.; Bijl, A.; Rotteveel, J.J.
	2006	Non-compliance on the part of the professional community with a national guideline: an argumentative policy analysis.	Moret-Hartman, M.; Knoester, P.D.; Hekster, Y.A.; Wilt, G.J. van der
	2006	Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients	Droste, J.A.H.; Kearney, B.P.; Hekster, Y.A.; Burger, D.M.
	2005	[Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression]	Lekkerkerker, J.F.F.; Schobben, A.F.; Dissel, J.T. van; Hekster, Y.A.; Hoes, A.W.; Mulder, G.J.; Neef, C.; Peeters, M.F.; Ree, J.M. van; Rosmalen, C.F.; Schellekens, H.; Schellens, J.H.M.; Silberbusch, J.
	2005	TDM: therapeutic drug measuring or therapeutic drug monitoring?	Droste, J.A.H.; Koopmans, P.P.; Hekster, Y.A.; Burger, D.M.
	2005	Cost-effectiveness of add-on lamotrigine therapy in clinical practice.	Knoester, P.D.; Boendermaker, A.J.; Egberts, A.C.G.; Hekster, Y.A.; Keyser, A.J.M.; Severens, J.L.; Renier, W.O.; Deckers, C.L.P.
	2005	Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.	Knoester, P.D.; Keyser, A.J.M.; Renier, W.O.; Egberts, A.C.G.; Hekster, Y.A.; Deckers, C.L.P.
	2005	Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not.	Knoester, P.D.; Belitser, S.V.; Deckers, C.L.P.; Keyser, A.J.M.; Renier, W.O.; Egberts, A.C.G.; Hekster, Y.A.
	2005	Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice.	Wilting, I.; Movig, K.L.L.; Moolenaar, M.; Hekster, Y.A.; Brouwers, J.R.B.J.; Heerdink, E.R.; Nolen, W.A.; Egberts, A.C.G.
	2005	Volume and market share of anti-epileptic drugs in The Netherlands: impact of new drugs.	Knoester, P.D.; Deckers, C.L.P.; Vaart, R. van der; Leufkens, H.G.; Hekster, Y.A.
	2005	Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.	Aarnoutse, R.E.; Kleinnijenhuis, J.; Koopmans, P.P.; Touw, D.J.; Wieling, J.; Hekster, Y.A.; Burger, D.M.
	2005	Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers.	Droste, J.A.H.; Verweij-van Wissen, C.P.W.G.M.; Kearney, B.P.; Buffels, R.; Horssen, P.J. van; Hekster, Y.A.; Burger, D.M.
	2005	Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.	Porte, C.J.L. la; Verweij-van Wissen, C.P.W.G.M.; Ewijk, N. van; Aarnoutse, R.E.; Koopmans, P.P.; Reiss, P.; Stek Jr, M.; Hekster, Y.A.; Burger, D.M.
	2004	Effectiveness of lamotrigine in daily practice : a multicentre chart review	Deckers, C.L.P.; Knoester, P.D.; Hekster, Y.A.; Keyser, A.J.M.; Renier, W.O.
	2004	Een patiënt met verminderde gevoeligheid voor acenocoumarol tijdens gebruik van sondevoeding.	Iersel, M.B. van; Blenke, A.A.M.; Kremer, H.P.H.; Hekster, Y.A.
	2004	Improving the process of antibiotic therapy in daily practice - Interventions to optimize timing, dosage adjustment to renal function, and switch therapy	Vogtlander, N.P.J.; Kasteren, M.E.E. van; Natsch, S.; Kullberg, B.J.; Hekster, Y.A.; Meer, J.W.M. van der
	2004	[A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding]	Iersel, M.D. van; Blenke, A.A.M.; Kremer, H.P.H.; Hekster, Y.A.
	2004	Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not.	Knoester, P.D.; Belitser, S.V.; Deckers, C.L.P.; Keyser, A.J.M.; Renier, W.O.; Egberts, A.C.G.; Hekster, Y.A.
	2004	Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice.	Knoester, P.D.; Belitser, S.V.; Deckers, C.L.P.; Keyser, A.J.M.; Renier, W.O.; Egberts, A.C.G.; Hekster, Y.A.
	2004	Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.	Vogtländer, N.P.J.; Kasteren, M.E.E. van; Natsch, S.S.; Kullberg, B.J.; Hekster, Y.A.; Meer, J.W.M. van der
	2004	Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands.	Knoester, P.D.; Belitser, S.V.; Deckers, C.L.P.; Keyser, A.J.M.; Renier, W.O.; Egberts, A.C.G.; Hekster, Y.A.
	2004	Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteers.	Porte, C.J.L. la; Graaff, M.J.A. de; Colbers, E.P.; Voncken, D.S.; Ibanez, S.M.; Koopmans, P.P.; Hekster, Y.A.; Burger, D.M.
	2004	Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.	Porte, C.J.L. la; Colbers, E.P.; Bertz, R.; Voncken, D.S.; Wikstrom, K.; Boeree, M.J.; Koopmans, P.P.; Hekster, Y.A.; Burger, D.M.
	2003	Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations	Natsch, S.; Kullberg, B.J.; Hekster, Y.A.; Meer, J.W.M. van der
	2002	Failure of prescribers to adjust antibiotic dose to impaired renal function in daily clinical practice	Vogtlander, N.P.J.; Kasteren, M.E.F. van; Natsch, S.; Kullberg, B.J.; Hekster, Y.A.; Meer, J.W.M. van der
	2001	Use of fluconazole in daily practice: still room for improvement	Natsch, S.; Steeghs, M.H.M.; Hekster, Y.A.; Meis, J.F.G.M.; Meer, J.W.M. van der; Kullberg, B.J.
	1999	Geregeld slikken	Hekster, Y.A.
	1998	Application of the ATC/DDD methodology to monitor antibiotic drug use	Natsch, S.; Hekster, Y.A.; Jong, R. de; Heerdink, E.R.; Herings, R.M.C.; Meer, J.W.M. van der
	1997	Lamivudine	Burger, D.M.; Hekster, Y.A.; Koopmans, P.P.
	1997	Meropenem (Meronem(R))	Daemen, H.J.G.; Burger, D.M.; Hekster, Y.A.; Donnelly, J.P.
	1997	Lamivudine (Epivir)	Burger, D.M.; Hekster, Y.A.; Koopmans, P.P.

1 2 next